Inventor · disambiguated record
Matthias Kloor
Also filed as: KLOOR MATTHIAS
6 granted patents·1 pending application·16 citations·filing 2005–2017
76Inventor score
Files withUNIV HEIDELBERG RUPRECHT KARLS3MTM LAB AG1RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG1Ruprecht-Karls-Universität Heidelberg 1UNIV RUPRECHT KARLS HEIDELBERG1
Top patents by PatentIndex Score
7 records- 0189US9205140B2MSI-specific frameshift peptides (FSP) for prevention and treatment of cancerUNIV RUPRECHT KARLS HEIDELBERG·Filed 2012·Granted Dec 8, 2015·11 cites·12 claims
- 0276US9770499B2MSI-specific frameshift peptides (FSP) for prevention and treatment of cancerRUPRECHT-KARLS-UNIVERSITAT HEIDELBERG·Filed 2015·Granted Sep 26, 2017·2 cites·7 claims
- 0374US9114101B2P16INK4A derived peptides for prophylaxis and therapy of HPV-associated tumors and other P16INK4A expressing tumorsUNIV HEIDELBERG RUPRECHT KARLS·Filed 2012·Granted Aug 25, 2015·1 cites·4 claims
- 0472US7662595B2Compounds and methods for assessment of microsatellite instability (MSI) statusMTM LAB AG·Filed 2005·Granted Feb 16, 2010·2 cites·11 claims
- 0563US10682402B2MSI-specific frameshift peptides (FSP) for prevention and treatment of cancerUNIV HEIDELBERG RUPRECHT KARLS·Filed 2017·Granted Jun 16, 2020·0 cites·13 claims
- 0644US9566319B2p16INK4a derived peptides for prophylaxis and therapy of HPV-associated tumors and other p16INK4a expressing tumorsRuprecht-Karls-Universität Heidelberg ·Filed 2015·Granted Feb 14, 2017·0 cites·7 claims
- 0737US2018169123A1Combination therapy with a flavagline and 2-deoxyglucoseUNIV HEIDELBERG RUPRECHT KARLS·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthias Kloor files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →